Effects of finasteride and bicalutamide on prostatic blood flow in the rat

BJU International

Volumn 85, Issue 7, 2000, Pages 962-965

  Lekas E ^c   Bergh, A ^a   Damber, Jan Erik ^a,b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

Bicalutamide; Blood flow; Finasteride; Microspheres; Prostate; Rat

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BICALUTAMIDE; ETHYLENE GLYCOL DIMESYLATE; FINASTERIDE; RADIOACTIVE MICROSPHERE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; CASTRATION; CONTROLLED STUDY; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE VENTRAL LOBE; RAT;

ANDROGEN ANTAGONISTS; ANILIDES; ANIMALS; ENZYME INHIBITORS; FINASTERIDE; MALE; ORGAN SIZE; PROSTATE; PROSTATIC DISEASES; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW;

EID: 0034092488     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00671.x     Document Type: Article

References (24)

1. 1 Lekås E. Johansson M, Widmark A, Bergh A, Damber J-E. Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration. Urol Res 1997; 25: 309-14
2. 2 Shabsigh A, Chang DT, Heitjan DF et al. Rapid reduction in blood flow to the rat ventral prostate gland after castration: Preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival. Prostate 1998; 36: 201-6
3. 3 Frank-Lissbrant I, Häggström S. Damber J-E, Bergh A. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology 1998; 139: 451-6
4. 4 Haggstrom S, Lissbrant IF, Bergh A, Damber JE. Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. J Urol 1999; 161: 1620-5
5. 5 Tyrrell CJ. Controversies in the management of advanced prostate cancer. Br J Cancer 1999; 79: 146-55
6. 6 Schafer W, Tammela TL, Barrett DM et al. Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years. Urology 1999; 54: 278-83
7. 7 Huynh H, Raouf MS, Brock GB. Reduction of ventral prostate weight by finasteride is associated with suppression of insulin-like growth factor 1 (IGF-1) and IGF-1 receptor genes and with an increase in IGF binding protein 3. Cancer Res 1998; 58: 215-8
8. 8 Puchner PJ, Miller MI. The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report. J Urol 1995; 194: 1779-82
9. 9 Carlin BI, Bodner DR, Spirnak JP, Resnick MI. Role of finasteride in the treatment of recurrent hematuria secondary to benign prostatic hyperplasia. Prostate 1997; 31: 180-2
10. 10 Sieber PR, Rommel FM, Huffnagle HW, Breslin JA, Agusta VE, Harpster LE. The treatment of gross hematuria secondary to prostatic bleeding with finasteride. J Urol 1998; 159: 1232-3
11. 11 Miller MI, Puchner PJ. Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up. Urology 1998; 51: 237-40
12. 12 Moon SY, Moon WC, Choi HR, Seoul YJ. Finasteride inhibits angiogenesis and expression of VEGF in human BPH. J Urol 1998; 159: 332 (abstract 1276)
13. 13 Goa KL, Spencer CM. Bicalutamide in advanced prostate cancer. A review. Drugs Aging 1998; 12: 401-22
14. 14 Furr BJ, Tucker H. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action. Urology 1996; 47: 13-25
15. 15 Jackson CM, Morris ID. Gonadotropin levels in male rats following impairment of Leydig cell function by ethane-1,2-dimethyl sulphonate. Andrologia 1977; 9: 29-35
16. 16 Rudolf AM, Heymann MA. The circulation of the fetus in vivo. Circ Res 1967; 21: 163-84
17. 17 Damber J-E, Janson P-O. Testicular blood flow and testosterone concentrations in spermatic venous blood of anaesthetized rats. J Reprod Fertil 1978; 52: 265-9
18. 18 Haggstrom S, Wikstrom P, Bergh A, Damber J-E. Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration. Prostate 1998; 36: 71-9
19. 19 Farnsworth WE. Prostate stroma: Physiology. Prostate 1999; 38: 60-72
20. 20 Hayek OR, Shabsigh A, Kaplan SA et al. Castration induces acute vasoconstriction of blood vessels in the rat prostate concomitant with a reduction of prostatic nitric oxide synthase activity. J Urol 1999; 162: 1527-31
21. 21 Pewitt EB, Haleem R, Wang Z. Adrenomedullin gene is abundantly expressed and directly regulated by androgen in the rat ventral prostate. Endocrinology 1999; 140: 2382-6
22. 22 Solomon MH, McHugh TA, Dorr RP, Lee F, Siders DB. Hormone ablation therapy as neoadjuvant treatment to radical prostatectomy. Clin Invest Med 1993; 16: 532-8
23. 23 Marshall S, Narayan P. Treatment of prostatic bleeding: suppression of angiogenesis by androgen deprivation. J Urol 1993; 149: 1553-4
24. 24 Soloway MS, Schellhammar PF, Smith JA Jr, Chodak GW, Vogelzang NJ, Kennealey GT. Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II noncomparative multicenter trial evaluating safety, efficacy, efficacy and long-term endocrine effects of monotherapy. J Urol 1995; 154: 2110-4